Spectroscopic diagnosis of chronic fatigue syndrome by visible and near-infrared spectroscopy in serum samples.

To investigate visible and near-infrared (Vis-NIR) spectroscopy enabling chronic fatigue syndrome (CFS) diagnosis, we subjected sera from CFS patients as well as healthy donors to Vis-NIR spectroscopy. Vis-NIR spectra in the 600-1100 nm region for sera from 77 CFS patients and 71 healthy donors were subjected to principal component analysis (PCA) and soft independent modeling of class analogy (SIMCA) to develop multivariate models to discriminate between CFS patients and healthy donors. The model was further assessed by the prediction of 99 masked other determinations (54 in the healthy group and 45 in the CFS patient group). The PCA model predicted successful discrimination of the masked samples. The SIMCA model predicted 54 of 54 (100%) healthy donors and 42 of 45 (93.3%) CFS patients of Vis-NIR spectra from masked serum samples correctly. These results suggest that Vis-NIR spectroscopy for sera combined with chemometrics analysis could provide a promising tool to objectively diagnose CFS.

[1]  P. Cowen,et al.  Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome , 2001, Psychological Medicine.

[2]  B. Natelson,et al.  Impaired oxygen delivery to muscle in chronic fatigue syndrome. , 1999, Clinical science.

[3]  B. Evengård,et al.  Absence of evidence of Borna disease virus infection in Swedish patients with Chronic Fatigue Syndrome. , 1999, Journal of neurovirology.

[4]  R. Emsley,et al.  Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities , 2001, Brain Research Bulletin.

[5]  J. Goldstein,et al.  Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome. , 2004, In vivo.

[6]  H. Heise,et al.  Noninvasive blood glucose sensors based on near-infrared spectroscopy. , 1994, Artificial organs.

[7]  I. Salit.  Post-infectious fatigue. , 1987, Canadian family physician Medecin de famille canadien.

[8]  W. Inder,et al.  Normal opioid tone and hypothalamic–pituitary–adrenal axis function in chronic fatigue syndrome despite marked functional impairment , 2005, Clinical endocrinology.

[9]  Simon Wessely,et al.  Chronic Fatigue Syndrome , 1996, BMJ : British Medical Journal.

[10]  Svante Wold,et al.  Pattern recognition by means of disjoint principal components models , 1976, Pattern Recognit..

[11]  Yasuyoshi Watanabe,et al.  Brain Science on Chronic Fatigue , 2006 .

[12]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[13]  R. Morehouse,et al.  Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome. , 1995, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[14]  T. Fearn,et al.  Near infrared spectroscopy in food analysis , 1986 .

[15]  Gwen Kennedy,et al.  Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. , 2005, Free radical biology & medicine.

[16]  R. Barnes,et al.  Standard Normal Variate Transformation and De-Trending of Near-Infrared Diffuse Reflectance Spectra , 1989 .

[17]  I. Jolliffe.  Principal Component Analysis , 2002 .

[18]  D L Massart,et al.  Use of a microcomputer for the definition of multivariate confidence regions in medical diagnosis based on clinical laboratory profiles. , 1984, Computers and biomedical research, an international journal.

[19]  R. Murray,et al.  Contrasting neuroendocrine responses in depression and chronic fatigue syndrome , 1995, Biological Psychiatry.

[20]  Masao Iwase,et al.  Brain Regions Involved in Fatigue Sensation: Reduced Acetylcarnitine Uptake into the Brain , 2002, NeuroImage.

[21]  J. Vecchiet,et al.  Chronic Fatigue Syndrome: Circadian Rhythm and Hypothalamic-Pituitary-Adrenal (HPA) Axis Impairment , 2001, International journal of immunopathology and pharmacology.

[22]  M. Demitrack,et al.  Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. , 1999, The Journal of rheumatology.

[23]  A. Savitzky,et al.  Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .

[24]  D. Tyrrell,et al.  Cytokines in parvovirus b19 infection as an aid to understanding chronic fatigue syndrome , 2003, Current pain and headache reports.

[25]  R. Morriss,et al.  A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. , 1998, Journal of affective disorders.

[26]  P. Vreken,et al.  Normal carnitine levels in patients with chronic fatigue syndrome. , 2000, The Netherlands journal of medicine.

[27]  K. Ikuta,et al.  Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome , 1996, FEBS letters.

[28]  Akikazu Sakudo,et al.  Near-infrared spectroscopy: Promising diagnostic tool for viral infections , 2006, Biochemical and Biophysical Research Communications.

[29]  P. Behan,et al.  Studies on enterovirus in patients with chronic fatigue syndrome. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.